Trademark: REZLIDHIA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for REZLIDHIA
We do not have any records of a proof of use for REZLIDHIA at this moment.
Possible trademark infringements of REZLIDHIA
Basic Information about REZLIDHIA
- Serial Number
- 97683809
- Filing Date
- 18 Nov 2022
- Registration Number
- 7253644
- Registration Date
- 26 Dec 2023
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of REZLIDHIA on the blockchain with WikiTrademarks.io.
- First use of REZLIDHIA anywhere
- REZLIDHIA was first used on 01 Dec 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns REZLIDHIA?
1. Rigel Pharmaceuticals, Inc. South San Francisco CA
2. Rigel Pharmaceuticals, Inc. South San Francisco CA
3. Rigel Pharmaceuticals, Inc. South San Francisco CA
Correspondent
- Diane J. Mason
- FAEGRE DRINKER BIDDLE & REATH LLP
- FOUR EMBARCADERO CENTER, 27TH FLOOR
- SAN FRANCISCO,CA 94111
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io